🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/09/2005 | 32,56 | 32,94 | 32,38 | 32,56 | +1,16% | 1,72% | 215.657 |
| 27/09/2005 | 32,49 | 33,09 | 32,19 | 32,19 | -0,81% | 2,77% | 224.046 |
| 26/09/2005 | 32,94 | 33,50 | 31,25 | 32,45 | +7,97% | 6,82% | 1.807.703 |
| 23/09/2005 | 27,89 | 30,13 | 27,47 | 30,06 | +8,51% | 9,53% | 435.535 |
| 22/09/2005 | 26,50 | 28,07 | 26,35 | 27,70 | +4,23% | 6,50% | 534.013 |
| 21/09/2005 | 28,82 | 28,82 | 26,28 | 26,58 | -7,67% | 8,83% | 605.320 |
| 20/09/2005 | 29,20 | 29,38 | 28,56 | 28,78 | -1,41% | 2,82% | 76.169 |
| 19/09/2005 | 29,23 | 29,76 | 29,20 | 29,20 | -1,39% | 1,92% | 44.083 |
| 16/09/2005 | 29,46 | 29,61 | 29,20 | 29,61 | +0,13% | 1,40% | 131.473 |
| 15/09/2005 | 30,32 | 30,66 | 29,42 | 29,57 | -2,47% | 4,07% | 442.455 |
| 14/09/2005 | 29,68 | 30,62 | 28,63 | 30,32 | -1,10% | 6,68% | 1.320.952 |
| 13/09/2005 | 31,07 | 32,19 | 29,20 | 30,66 | -6,93% | 9,64% | 1.965.412 |
| 12/09/2005 | 31,63 | 33,13 | 31,25 | 32,94 | +3,53% | 5,92% | 273.979 |
| 09/09/2005 | 28,82 | 32,38 | 28,82 | 31,82 | +9,25% | 12,34% | 458.084 |
| 08/09/2005 | 27,77 | 29,35 | 27,44 | 29,12 | +4,71% | 6,87% | 764.284 |
| 07/09/2005 | 26,09 | 28,07 | 26,01 | 27,81 | +6,14% | 7,89% | 2.534.183 |
| 06/09/2005 | 25,75 | 28,18 | 25,75 | 26,20 | -7,77% | 9,45% | 2.125.765 |
| 02/09/2005 | 28,82 | 29,01 | 28,07 | 28,41 | -0,65% | 3,25% | 113.653 |
| 01/09/2005 | 27,70 | 29,35 | 26,87 | 28,60 | -2,68% | 8,92% | 247.904 |
| 31/08/2005 | 29,46 | 29,79 | 29,01 | 29,38 | -0,76% | 2,67% | 176.490 |
| 30/08/2005 | 29,53 | 29,76 | 29,23 | 29,61 | -0,25% | 1,77% | 118.675 |
| 29/08/2005 | 29,49 | 29,87 | 29,08 | 29,68 | +0,76% | 2,66% | 246.702 |
| 26/08/2005 | 30,51 | 30,51 | 29,16 | 29,46 | -3,44% | 4,42% | 128.935 |
| 25/08/2005 | 30,39 | 30,84 | 30,32 | 30,51 | +0,25% | 1,72% | 231.687 |
| 24/08/2005 | 29,53 | 30,51 | 28,41 | 30,43 | +2,91% | 7,10% | 316.486 |
| 23/08/2005 | 29,72 | 30,28 | 29,49 | 29,57 | -0,38% | 2,64% | 182.902 |
| 22/08/2005 | 29,16 | 29,94 | 28,97 | 29,68 | +1,80% | 3,34% | 237.832 |
| 19/08/2005 | 28,48 | 29,42 | 28,48 | 29,16 | +1,96% | 3,28% | 223.512 |
| 18/08/2005 | 26,50 | 28,97 | 26,46 | 28,60 | +6,85% | 9,46% | 290.009 |
| 17/08/2005 | 26,72 | 27,51 | 26,28 | 26,76 | -0,14% | 4,62% | 94.470 |